The role of platelet cyclooxygenase and lipoxygenase pathways in tumor cell induced platelet aggregation
Authors:
- Kenneth V. HonnKHKenneth V. Honn
- Bruce W. SteinertBSBruce W. Steinert
- Kamiar MoinKMKamiar Moin
- James M. OnodaJOJames M. Onoda
- John D. TaylorJTJohn D. Taylor
- Bonnie F. SloaneBSBonnie F. Sloane
- 1 May 1987
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 145 (1) , 384-389
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Studies and Perspectives of Protein Kinase CScience, 1986
- Inhibition of rabbit platelet activation by lipoxygenase products of arachidonic and linoleic acidThrombosis Research, 1986
- Lipoxygenase products: Leukotrienes C4, D4, A4's breakdown products and 12-HPETE influence platelet aggregation in vivoProstaglandins, 1985
- Arachidonic acid-induced human platelet aggregation independent of cyclooxygenase and lipoxygenaseProstaglandins, 1984
- Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 systemClinical & Experimental Metastasis, 1983
- Nafazatrom (bay g 6575) inhibition of tumor cell lipoxygenase activity and cellular proliferationFEBS Letters, 1982
- Prostacyclin: A Potent Antimetastatic AgentScience, 1981